Pathophysiological Insights into AD and New Therapeutic Developments

At ISID 2023 | May 10, 2023 | 12:00 to 15:00 (12:00 - 3:00 PM) JST (Japan Standard Time)

Keio Plaza Hotel (Tokyo, Japan) | Room H (Fuji Room)

The IEC symposium will take place prior to the International Society for Investigative Dermatology Meeting 2023 (ISID) in Tokyo, Japan.  

REGISTER TODAY

PROGRAM CHAIRS

Kenji Kabashima, MD, PhD Kyoto, Japan		Emma Guttman, MD, PhD New York, NY, USA		Carolyn Jack, MDCM, PhD, FRCPC Montreal, Canada

AGENDA

12:00 – 12:10 PM Welcome & Program Overview | Robert Bissonnette, MD, FRCPC; IEC President & Kenji Kabashima, MD, PhD; IEC Secretary | Symposium Co-Chair

12:10 – 12:30 PM Endotypes of Atopic Dermatitis | Yoshiki Tokura, MD, PhD

12:30 – 1:00 PM Neuroinflammatory Circuits | Gil Yosipovitch, MD FAAD | IEC Coucilor

1:00 – 1:15 PM Flash Talk #1 | High-dimensional analysis identifies variably persistent activated skin-homing Th2/Tc2 populations in AD patients on Dupilumab | Carolyn Jack, MDCM, PhD, FRCPC | McGill University | Montreal, Canada 

1:15 – 1:30 PM Flash Talk #2 | The role of OX40/OX40L axis in atopic dermatitis | Kazuhiko Yamamura, MD, PhD | Kyushu University | Fukuoka, Japan

1:30 – 1:45 PM BREAK

1:45 – 2:05 PM Systemic Inflammation in AD | Patrick Brunner, MD | IEC Councilor

2:05 – 2:25 PM Identifying Early Predicting Factors for AD and Atopy | Helen He, MD

2:25 – 2:45 PM Biomarkers helping with AD therapeutic development | Emma Guttman, MD, PhD, IEC Immediate Past President and Co-Founder

2:45 – 3:00 PM Closing Comments | Emma Guttman, MD, PhD & Carolyn Jack, MDCM, PhD, FRCPC, IEC Associate | Symposium Co-Chairs

This educational symposium presented by the IEC is offered at no cost to attendees.

HEALTH AND SAFETY TRAVEL RESOURCES

IEC will comply with ISID and local mandates at the time of the in-person meeting.   Learn more on the ISID Coronavirus-Related Information page.